Prions – Focused Exam Notes
Definition & Key Features
- Prions: infectious, misfolded host proteins causing transmissible spongiform encephalopathies (TSEs)
- No nucleic-acid genome, <100\,\text{nm} in size
- Cannot be cultured in vitro; elicit no immune/inflammatory response
- Extremely resistant to heat, standard disinfectants, irradiation; inactivated by high phenol, periodate, NaOH, NaClO
- Incubation can extend to ≈35 years
Major Human & Animal TSEs
- Humans: kuru, sporadic CJD, familial CJD, variant CJD (vCJD)
- Animals: bovine spongiform encephalopathy (BSE; “mad cow”), scrapie (sheep)
Molecular Pathogenesis
- Normal neuronal glycoprotein: PrPC (linear, enzyme-susceptible, membrane-bound)
- Pathogenic isoform: PrPSc (globular, protease-resistant)
- PrPSc binds PrPC → converts it to PrPSc → self-propagating cycle
- Aggregated PrPSc forms amyloid fibrils/plaques → neuronal loss → spongiform brain appearance
Transmission Routes
- Oral ingestion of contaminated tissue (e.g., BSE→vCJD; kuru via cannibalism)
- Contaminated medical products or instruments (blood, grafts, neurosurgery tools)
- Possible but low mother-to-fetus transfer
- Prions survive digestion; uptake across intestine, carriage in white blood cells
Zoonotic Considerations
- Cross-species spread less efficient but significant (BSE → humans; scrapie → cattle)
- vCJD: younger patients, shorter incubation; outbreak linked to meat from BSE-infected cattle fed scrapie-contaminated offal
Genetic Susceptibility
- PRNP gene on chromosome 20 encodes PrPC
- Homozygosity at codon 129 polymorphism strongly associated with vCJD and kuru cases
- Heterozygosity may confer resistance or prolonged incubation
- Sheep breeds exhibit variable scrapie resistance; similar findings in mice
Diagnosis
- Clinical clue: rapidly progressive dementia → death <1 year in ∼90% of cases
- Supportive tests:
• MRI: cortical/basal ganglia degeneration (non-specific)
• Immunoblot of tonsil or blood for PrPSc
• Genetic testing for PRNP codon 129 status (risk, not confirmation)
• Definitive post-mortem neuropathology - New in vivo assay: RT-QuIC on CSF – recombinant PrP + patient sample + dye + shaking → fibril-induced fluorescence indicates PrPSc presence
Treatment & Prevention
- No curative therapy; care is supportive
- Experimental: monoclonal antibody PRN100 showed early promise (2022)
- Prevention: strict feed regulations (no offal), food-chain surveillance, rigorous decontamination of instruments